1,040
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

HOXC-AS2 mediates the proliferation, apoptosis, and migration of non-small cell lung cancer by combining with HOXC13 gene

, , , &
Pages 236-246 | Received 16 Jul 2020, Accepted 20 Dec 2020, Published online: 11 Jan 2021

References

  • Rotenberg Z, Weinberger I, Sagie A, et al. Total lactate dehydrogenase and its isoenzymes in serum of patients with non-small-cell lung cancer. Clin Chem. 1988;34:668–70.
  • Siegel RL, Miller KD. Cancer Statistics, 2020. Multicenter Study. 2020;70:7–30.
  • Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17:47–62.
  • Donato L, Scimone C, Alibrandi S, et al. Transcriptome Analyses of lncRNAs in A2E-Stressed Retinal Epithelial Cells Unveil Advanced Links between Metabolic Impairments Related to Oxidative Stress and Retinitis Pigmentosa. Antioxidants (Basel). 2020;9:318.
  • Sun W, Zu Y, Fu X, et al. Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy. Oncol Rep. 2017;38:3347–3354.
  • Lei Y, Guo W, Chen B, et al. Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer. Oncol Rep. 2018;40:3438–3446.
  • Shi X, Liu Z, Liu Z, et al. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer. EBioMedicine. 2018;37:177–187.
  • Yang R, Liu N, Chen L, et al. GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3-mediated deubiquitination of LSH. Oncogene. 2019;38:7133–7145.
  • Dong N, Guo J, Han S, et al. Positive feedback loop of lncRNA HOXC-AS2/miR-876-5p/ZEB1 to regulate EMT in glioma. Onco Targets Ther. 2019;12:7601–7609.
  • Fu T, Ji X, Bu Z, et al. Identification of key long non-coding RNAs in gastric adenocarcinoma. Cancer Biomark. 2020;27:541–553.
  • Awgulewitsch A. Overexpression of Hoxc13 in differentiating keratinocytes results in downregulation of a novel hair keratin gene cluster and alopecia. Development. 2001;128:1547–1558.
  • Liu M, Zhao S, Lin Q, et al. YAP regulates the expression of Hoxa1 and Hoxc13 in mouse and human oral and skin epithelial tissues. Mol Cell Biol. 2015;35:1449–1461.
  • Luo J, Wang Z, Huang J, et al. HOXC13 promotes proliferation of esophageal squamous cell carcinoma via repressing transcription of CASP3. Cancer Sci. 2018;109:317–329.
  • Stark R, Grzelak M. RNA sequencing: the teenage years. Nat Rev Genet. 2019;20:631–656.
  • Rinaldi C, Bramanti P, Scimone C, et al. Relevance of CCM gene polymorphisms for clinical management of sporadic cerebral cavernous malformations. J Neurol Sci. 2017;380:31–37.
  • Scimone C, Donato L, Katsarou Z, et al. Two Novel KRIT1 and CCM2 Mutations in Patients Affected by Cerebral Cavernous Malformations: new Information on CCM2 Penetrance. Front Neurol. 2018;9:953.
  • Donato L, D’Angelo R, Alibrandi S, et al. Effects of A2E-Induced Oxidative Stress on Retinal Epithelial Cells: new Insights on Differential Gene Response and Retinal Dystrophies. Antioxidants (Basel). 2020;9:307.
  • Donato L, Scimone C. Discovery of GLO1 New Related Genes and Pathways by RNA-Seq on A2E-Stressed Retinal Epithelial Cells Could Improve Knowledge on Retinitis Pigmentosa. Antioxidants (Basel).2020;9:416.
  • Li XN, Wang ZJ, Ye CX, et al. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer. J Exp Clin Cancer Res. 2018;37:325.
  • Su P, Wang F, Qi B, et al. P53 Regulation-Association Long Non-Coding RNA (LncRNA PRAL) Inhibits Cell Proliferation by Regulation of P53 in Human Lung Cancer. Med Sci Monit. 2017;23:1751–1758.
  • Wada R, Arai H, Kure S, et al. “Wild type” GIST: clinicopathological features and clinical practice. Pathol Int. 2016;66:431–437.
  • Rooij JD, Beuling E, Fornerod M, et al. ETV6 Aberrations Are a Recurrent Event in Pediatric Acute Myeloid Leukemia with Poor Clinical Outcome. Blood. 2014;124(21): 1012-1012.
  • Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.
  • Xu Y, Zhang J, Liu X, et al. MMP-2-responsive gelatin nanoparticles for synergistic tumor therapy. Pharm Dev Technol. 2019;24:1–26.
  • Kang C. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol Rep. 2013;29(4):1579–1587.
  • Zhang J, Jiang T, Liang X, et al. lncRNA MALAT1 mediated high glucose-induced HK-2 cell epithelial-to-mesenchymal transition and injury. J Physiol Biochem. 2019;75:443–452.
  • Li C, Cui J, Zou L, et al. Bioinformatics analysis of the expression of HOXC13 and its role in the prognosis of breast cancer. Oncol Lett. 2020;19:899–907.
  • Kasiri S, Ansari KI, Hussain I, et al. Antisense oligonucleotide mediated knockdown of HOXC13 affects cell growth and induces apoptosis in tumor cells and over expression of HOXC13 induces 3D-colony formation. RSC Adv. 2013;3:3260–3269.
  • Yao Y, Luo J, Sun Q, et al. HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1. Am J Cancer Res. 2017;7:1820–1834.
  • Chiara AD. Hyperexpression of HOXC13, located in the 12q13 chromosomal region, in well-differentiated and dedifferentiated human liposarcomas. Oncol Rep. 2013;30:2579–86.
  • Marcinkiewicz KM, Gudas LJ. Altered Histone Mark Deposition and DNA Methylation at Homeobox Genes in Human Oral Squamous Cell Carcinoma. J Cell Physiol. 2014;229:1405–1416.
  • Komisarof J, McCall M, Newman L, et al. A four gene signature predictive of recurrent prostate cancer. Oncotarget. 2017;8:3430–3440.
  • Luo J, Wang Z, Huang J, et al. HOXC13 promotes proliferation of esophageal squamous cell carcinoma via repressing transcription of CASP3. Cancer Sci. 2018;109:317–329.
  • Yang C, Zhang J, Ding M, et al. Ki67 targeted strategies for cancer therapy. Clin Transl Oncol. 2018;20:570–575.
  • Li LT, Jiang G, Chen Q, et al. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep. 2015;11:1566–1572.
  • Yerushalmi R, Woods R, Ravdin PM, et al. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol. 2010;11:174–183.
  • Li H, Han X, Liu Y, et al. Ki67 as a predictor of poor prognosis in patients with triplenegative breast cancer. Oncol Lett. 2015;9:149–152.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.